Gabriel Grego of Quintessential Capital Updates Investors On One Of His Big Short [VIS Italy Conference]

Michelle deBoer-Jones

Published onJuly 8, 2024

The longer the stock markets are open for business, it seems like the more companies find different ways of potentially ripping of investors.

At the 20^th annual Value Investing Seminar in Trani, Italy, Gabriel Grego of Quintessential Capital discussed a variety of unethical practices in the pharmaceutical industry, including falsified clinical trials and alleged stock-price manipulation.

He highlighted

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Michelle deBoer-Jones

Michelle deBoer-Jones is editor-in-chief of Hedge Fund Alpha. She also writes comparative analyses of stocks for TipRanks and runs Providence Writing Services. Previously, she was a television news producer for eight years, producing the morning news programs for NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spending a short time at the CBS affiliate in Huntsville.

Gabriel Grego of Quintessential Capital Updates Investors On One Of His Big Short [VIS Italy Conference]

Login required to continue reading.

Get Your Business News